Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): Interactions with the retinoic acid receptors

Toxicology and Applied Pharmacology

Volumn 159, Issue 2, 1999, Pages 109-116

  Pignatello, Michael A ^a,b   Kauffman, Frederick C ^a   Levin, Arthur A ^c  

^a RUTGERS UNIVERSITY   (United States)

^b Hoffmann La Roche Department of Toxicology and Pathology   (United States)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; BINDING PROTEIN; COMPLEMENTARY DNA; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DOSE RESPONSE; GENE; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; RECEPTOR OCCUPANCY; TOXICITY;

EID: 0033200382     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8726     Document Type: Article

References (52)

1. Allenby G., Bocquel M. T., Saunders M., Kazmer S., Speck J., Rosenberger M., Lovey A., Kastner P., Grippo J. F., Chambon P., Levin A. A. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA. 90:1993;30-34.
2. Allenby G., Janocha R., Kazmer S., Speck J., Grippo J. F., Levin A. A. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors α, β, and γ J. Biol. Chem. 269:1994;16689-16695.
3. Armstrong R. B., Kim H-J., Grippo J. F., Levin A. A. Retinoids for the future: Investigational approaches for the identification of new compounds. J. Am. Acad. Dermatol. 27:1992;S38-S42.
4. Åström A., Pettersson U., Krust A., Chambon P., Voorhees J. J. Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem. Biophys. Res. Commun. 173:1990;339-345.
5. Beale E. G., Deeb E. A., Handley R. S., Akhavan-Tafti H., Schaap A. P. A rapid and simple chemiluminescent assay for Escherichia coli beta-galactosidase. Biotechniques. 12:1992;320-323.
6. Bollag W. Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice. Eur. J. Cancer. 10:1974;731-737.
7. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
8. 2-microglobulin in F9 teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78:1981;5754-5758.
9. Darmon M., Rocher M., Cavey M. T., Martin B., Rabilloud T., Delescluse C., Shroot B. Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. Skin Pharmacol. 1:1988;161-175.
10. Dawson M. I., Hobbs P. D., Stein R. B., Berger T. S., Heyman R. A. Interaction of retinoids with retinoic acid nuclear receptor isoforms. Retinoids. Progress in Research and Clinical Applications. 1993;Marcel Dekker, New York. p. 205-221.
11. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol. 235:1978;E97-E102.
12. DeLuca M., McElroy W. D. Purification and properties of firefly luciferase. Methods Enzymol. 57:1978;3-15.
13. de Thé H., Vivanco-Ruiz M., Tiollais P., Stunnenberg H., Dejean A. Identification of a retinoic acid response element in the retinoic acid receptor β gene. Nature (Lond.). 343:1990;177-180.
14. DeWet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S. Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell. Biol. 7:1987;725-737.
15. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
16. Geelen J. A. G. Hypervitaminosis A induced teratogenesis. Crit. Rev. Toxicol. 6:1979;351-375.
17. Green S., Issemann I., Sheer E. A Versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:1988;369.
18. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F. F., Zamir I., Seiser C., Grignani Fa., Lazar M. A., Minucci S., Pelicci P. G. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature. 391:1998;815-818.
19. Grippo J. F., Gudas L. J. The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity. J. Biol. Chem. 262:1987;4492-4500.
20. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
21. Howard W. B., Willhite C. C., Sharma R. P., Omaye S. T., Hatori A. Pharmacokinetics, tissue distribution and placental permeability of tetrahydro-tetramethyl-naphthalenyl-propenyl benzoic acid (a retinoidal benzoic acid derivative) in hamsters. Eur. J. Drug Metab. Pharmocokinet. 14:1989;153-159.
22. Kamm J. J., Ashenfelter K. O., Ehmann C. W. Preclinical and clinical toxicology of selected retinoids. Sporn M. B., Roberts A. B., Goodman D. S. The Retinoids. 1984;287-326 Academic Press, New York.
23. Kistler A. Structure-activity relationship of retinoids in fetal rat bone cultures. Calcif. Tissue Int. 33:1981;249-254.
24. Kistler A., Galli B., Howard W. B. Comparative teratogenicity of three retinoids: The arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570. Arch. Toxicol. 64:1990;43-48.
25. Kochhar D. M. Mechanisms by which retinoids intercept developmental events of the mammalian limb. Welsch F. Approaches to Elucidate Mechanisms of Teratogenesis. 1987;197-213 Hemisphere Publishing, New York.
26. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A., Moore D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
27. Lehmann J. M., Dawson M. I., Hobbs P. D., Husmann M., Pfahl M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res. 51:1991;4804-4809.
28. Leid M., Kastner P., Chambon P. Multiplicity generates diversity in the retinoic acid signaling pathways. TIBS. 17:1992;427-433.
29. Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J. F. A new pathway for vitamin A: Understanding the pleiotropic effects of retinoids. Ann. NY Acad. Sci. 669:1992;70-85.
30. Limbird L. E. Cell Surface Receptors: A Short Course on Theory and Methods. 1996;Kluwer Academic Publishers, Norwell. p. 61-122.
31. Lippman S. M., Kessler J. F., Meyskens F. L. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat. Rep. 71:1987a;391-405.
32. Lippman S. M., Kessler J. F., Meyskens F. L. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat. Rep. 71:1987b;493-515.
33. Loeliger P., Bollag W., Mayer H. Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. 1:1980;9-15.
34. Maniatis T., Fritsch E. F., Sambrook J. Isolation of bacteriophage λ and plasmid DNa. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory, New York. p. 75-96.
35. Marotti K. R., Brown G. D., Strickland S. Two-stage hormonal control of type IV collagen mRNA levels during differentiation of F9 teratocarcinoma cells. Dev. Biol. 108:1985;26-31.
36. Meier C. A. Regulation of gene expression by nuclear hormone receptors. J. Recept. Signal Transduct. Res. 17:1997;319-335.
37. Nervi C., Grippo J. F., Sherman M. I., George M. D., Jetton A. M. Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc. Natl. Acad. Sci. USA. 86:1989;5854-5858.
38. Pignatello M. A., Kauffman F. C., Levin A. A. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): Binding affinities and disposition. Toxicol. Appl. Pharmacol. 142:1997;319-327.
39. Potter H., Weir L., Leder P. Enhancer-dependent expression of human κ immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA. 81:1984;7161-7165.
40. Roberts A. B., Sporn M. B. Role of retinoids in differentiation and carcinogenesis. J. Natl. Cancer Inst. 73:1984;1381-1387.
41. Rosenthal H. A graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 20:1967;525-532.
42. Saurat J. H. Retinoids: New Trends in Research and Therapy. 1984;Karger, Basel.
43. Scatchard G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:1949;660-672.
44. Smith S. M., Levy N. S., Hayes C. E. Impaired immunity in vitamin A-deficient mice. J. Nutr. 117:1987;857-865.
45. Strickland S., Breitman T. R., Frickel F., Nurrenbach A., Hadicke E., Sporn M. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res. 43:1983;5268-5272.
46. Tate B. F., Allenby G., Janocha R., Kazmer S., Speck J., Sturzenbecker L. J., Abarzua P., Levin A. A., Grippo J. F. Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor α Mol. Cell. Biol. 14:1994;2323-2330.
47. Thaller C., Eichele G. Isolation of 3′4-didehydroretinoic acid: A novel morphogenetic signal in the chick wing bud. Nature. 345:1990;815-819.
48. Thompson J. N., Howell J. M., Pitt G. A. J. Vitamin A and reproduction in rats. Proc. R. Soc. Lond. Biol. Sci. 159:1964;510-535.
49. Wang S., Gudas L. J. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc. Natl. Acad. Sci. USA. 80:1983;5880-5884.
50. Warkany J., Nelson R. C. Appearance of skeletal abnormalities in offspring of rats reared on deficient diet. Science. 92:1940;383-384.
51. Wilson J. G. Principles of teratology. Environment and Birth Defects. 1973;Academic Press, New York. p. 11-34.
52. Wolffe A. P. Sinful repression. Nature. 387:1997;16-17.